The 2017 Melanoma Focus Regional Meeting will take place at The Research Beehive, Newcastle University on Friday 19 May. The Organisers are Professor Penny Lovat, Professor Ruth Plummer and Dr Rob Ellis. CPD accreditation has been awarded by The Royal College of Physicians and The Royal College of Surgeons.
Posters are welcome at this meeting. Authors should submit their abstracts to firstname.lastname@example.org by 1 May. Late posters may be accepted, subject to available space, but will not be included in the delegate brochure.
Please click here to register – earlybird and membership discounts are available. Space is limited so early registration is recommended.
For travel directions, parking information and a campus map click here. The meeting will be held in The Research Beehive, Old Library Building, Newcastle upon Tyne NE1 7RU (key no. 25, just right of centre on the campus map).
For a .pdf version of the programme click here.
Registration and Poster Setup
Welcome and Introduction: Professor Ruth Plummer and Professor Penny Lovat
Session 1: Early Diagnosis, Biomarkers and Current Management of Metastatic Melanoma
Chair: Professor Penny Lovat
Dr Rob Ellis & Professor Penny Lovat, Newcastle University: Prognostic biomarkers of early stage melanoma: combined loss of epidermal AMBRA1 and loricrin is a prognostic biomarker for AJCC stage I melanomas
Dr Antoni Ribas, Ronald Reagan UCLA Medical Center, Los Angeles: Recent advances in our understanding of melanoma
Introduced by Professor Paul Lorigan, The Christie
Professor Christian Ottensmeier, University Hospital Southampton NHS Foundation Trust: Advances in immunotherapy
Dr Gabriela Gremel, Cancer Research UK Manchester Institute: Clinical utility of circulating tumour DNA monitoring for patients with melanoma undergoing systemic therapy
Simon Rodwell, Melanoma Focus: Update on the Melanoma Helpline
Lunch and Poster Viewing/Discussion
Session 2: Pre-Clinical and Clinical Developments
Chair: Professor Ruth Plummer
Dr Ashleigh McConnell, Newcastle University: Increasing the efficacy of targeted MEK inhibition for uveal melanoma through dual inhibition of autophagy
Dr Paul Nathan: Trials in areas of unmet need – uveal melanoma, mucosal melanoma and brain metastases
Case Presentations & Panel Discussion: Managing toxicities of combination therapies
Led by: Professor Ruth Plummer, Professor Paul Lorigan and Dr Antoni Ribas
Panel Members: Dr Paul Nathan, Mount Vernon Cancer Centre; Ms Nikki Hunter, The Royal Marsden; and Dr Miranda Payne, Oxford University
Session 3: Clinical Trials
Chair: Professor Paul Lorigan
Professor Ruth Plummer, Sir Bobby Robson Cancer Treatment Centre & Newcastle University: The changing face of clinical trials
Dr Tobian Muir, James Cook University, Middlesbrough: ECT in metastatic melanoma
Summary and Close